Palvella Therapeutics, Inc. PVLA

138.16 (7.91) (5.42%) as of 25 Sep
Market cap
$2.1B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Net Income
(61.70) (49.30) (41.71) (32.95)

+8 more TTM periods

Non Cash Items (Other)
20.26 15.82 12.89 11.02
Accounts Receivable Change
— — 1.10 6.38
Accounts Payable Change
2.22 0.99 1.26 0.15
Change in payables and accrued liability
1.68 0.71 (1.30) (1.95)
Change in other assets and liabilities
0.63 2.29 3.47 (2.10)
Operating Cash Flow
(36.51) (29.10) (25.01) (25.47)
Long-Term Investments Change (Net)
(44.47) (28.44) — —
Investing cash flow
(39.98) (23.95) — —
Equity Repurchase (Common, Net)
232.58 231.65 0.76 0.67
Other financial activities
(16.38) (16.38) (1.42) 67.52
Financing cash flow
216.20 215.27 (0.66) 74.17
Exchange Rate Adjustment
0.15 0.04 0.05 0.66
Change in Cash
117.37 130.77 (25.62) 49.36
Beginning Cash
57.98 57.98 83.60 83.60
Ending Cash
175.35 188.75 57.98 132.96
Stock Based Compensation
12.41 8.68 6.40 4.59
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
4.92 4.38 3.82 (3.54)
Investments Change (Net)
(44.47) (28.44) — —
Issuance/Purchase of Shares
232.58 231.65 0.76 0.67

Fold the line items

In millions of $ except per-share values · columns are period end dates